Once-daily long-acting beta₂-agonists/inhaled corticosteroids combined inhalers versus inhaled long-acting muscarinic antagonists for people with chronic obstructive pulmonary disease-Reference-Cited by-同舟云学术

Once-daily long-acting beta₂-agonists/inhaled corticosteroids combined inhalers versus inhaled long-acting muscarinic antagonists for people with chronic obstructive pulmonary disease

Published:2018-08-24 Issue:8 Volume:2018 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Sliwka Agnieszka¹,Jankowski Milosz²,Gross-Sondej Iwona³,Storman Monika⁴,Nowobilski Roman⁵,Bala Malgorzata M⁶

Affiliation:

1. Jagiellonian University Medical College; Institute of Physiotherapy, Faculty of Health Science; Krakow Poland

2. Jagiellonian University Medical College; Department of Anaesthesiology and Intensive Care, The University Hospital in Krakow; II Department of Internal Medicine; Systematic Reviews Unit - Polish Cochrane Branch,; Krakow Poland

3. The University Hospital in Krakow; Krakow Poland

4. Systematic Reviews Unit Polish Cochrane Branch (Cochrane Poland); Krakow Poland

5. Jagiellonian University Medical College; Faculty of Health Science; Krakow Poland

6. Jagiellonian University Medical College; Chair of Epidemiology and Preventive Medicine; Department of Hygiene and Dietetics; Systematic Reviews Unit - Polish Cochrane Branch; Kopernika 7 Krakow Poland 31-034

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012355.pub2/epdf/full

Reference74 articles.

1. Efficacy and safety of fluticasone furoate/vilanterol or tiotropium in subjects with COPD at cardiovascular risk;Covelli;International Journal of Chronic Obstructive Pulmonary Disease,2016

2. Long-acting bronchodilators and arterial stiffness in patients with COPD: a comparison of fluticasone furoate/vilanterol with tiotropium;Pepin;Chest,2014

3. Rubin DB Pepin J-L Cockcroft JR Midwinter D Sharma S Andreas S Long-acting bronchodilators and arterial stiffness in patients with COPD American Journal of Respiratory and Critical Care Medicine 2013 A6027

4. A pilot study comparing tiotropium to salmeterol plus fluticasone in moderate COPD;Bateman;European Respiratory Journal,2005

5. Comparable spirometric efficacy of tiotropium compared with salmeterol plus fluticasone in patients with COPD: a pilot study;Bateman;Pulmonary Pharmacology and Therapeutics,2008

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overcoming Therapeutic Inertia to Reduce the Risk of COPD Exacerbations: Four Action Points for Healthcare Professionals;International Journal of Chronic Obstructive Pulmonary Disease;2021-11

2. Long-Acting Bronchodilators for Chronic Obstructive Pulmonary Disease;Clinics in Chest Medicine;2020-09

3. Animal Models Reflecting Chronic Obstructive Pulmonary Disease and Related Respiratory Disorders: Translating Pre-Clinical Data into Clinical Relevance;Journal of Innate Immunity;2019-09-17

4. For people with chronic obstructive pulmonary disease (COPD), how does once-daily inhaled fluticasone plus vilanterol compare with tiotropium?;Cochrane Clinical Answers;2019-06-17